|
Volumn 267, Issue 7169, 2001, Pages 518-
|
Hospital pharmacists and the NSF for CHD
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALTEPLASE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
FIBRINOLYTIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
OPIATE;
OXYGEN;
RETEPLASE;
SPIRONOLACTONE;
STREPTOKINASE;
ACUTE HEART INFARCTION;
BLOOD PRESSURE REGULATION;
CONFERENCE PAPER;
CONTROLLED STUDY;
DIABETES CONTROL;
EMERGENCY;
FEEDING BEHAVIOR;
FIBRINOLYTIC THERAPY;
HEALTH PROMOTION;
HIGH RISK PATIENT;
HOSPITAL DISCHARGE;
HOSPITAL PHARMACY;
HUMAN;
ISCHEMIC HEART DISEASE;
LIFESTYLE;
MORTALITY;
PAIN;
PALLIATIVE THERAPY;
PATIENT EDUCATION;
PATIENT INFORMATION;
PATIENT TRANSPORT;
PHARMACIST;
PRESCRIPTION;
PUBLIC HEALTH SERVICE;
RESPONSIBILITY;
SMOKING CESSATION;
|
EID: 85083923439
PISSN: 00316873
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (3)
|
References (0)
|